DEF 14A

Company

Viridian Therapeutics, Inc.\DE

Filed

December 14, 2020

Period of Report

December 31, 2020

Accession Number

0001193125-20-316082

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →